Oral administration of Limosilactobacillus reuteri VHProbi® M07 alleviates ovalbumin-induced allergic asthma in mice
Saved in:
Main Authors: | Guoqing Meng, Hongchang Cui, Congrui Feng, Chaoqun Guo, Lei Song, Zhi Duan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737801/?tool=EBI |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral administration of Limosilactobacillus reuteri VHProbi® M07 alleviates ovalbumin-induced allergic asthma in mice.
by: Guoqing Meng, et al.
Published: (2025-01-01) -
Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis
by: Ningning Yue, et al.
Published: (2025-01-01) -
Limosilactobacillus reuteri - a probiotic gut commensal with contextual impact on immunity
by: Amanda H. Lee, et al.
Published: (2025-12-01) -
Stigmasterol Modulates Allergic Airway Inflammation in Guinea Pig Model of Ovalbumin-Induced Asthma
by: Aaron Opoku Antwi, et al.
Published: (2017-01-01) -
Biological Characteristics Analysis of Limosilactobacillus reuteri JBR3 and the Effect of Protective Agents on Its Viability
by: Jun HAN, et al.
Published: (2025-02-01)